COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
PolyPeptide with record revenue growth of 43% in H2 2023 versus H1 2023; operational improvements yielding increased profitability and cash flow
PolyPeptide announces record revenue growth of 43% in H2 2023 compared to H1 2023, along with enhanced profitability and cash flow. Details on 2023 results and 2024 guidance provided -
-
COMMUNIQUÉ DE PRESSE
Affluent Medical annonce le succès de la première implantation chez l’homme de son sphincter artificiel Artus pour le traitement de l’incontinence urinaire d’effort.
Affluent Medical annonce le succès de la première implantation chez l'homme de son sphincter artificiel Artus pour le traitement de l'incontinence urinaire d'effort -
COMMUNIQUÉ DE PRESSE
Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence.
Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence in Prague, Czech Republic. The innovative medical device offers hope for the estimated 400 million patients affected worldwide -
COMMUNIQUÉ DE PRESSE
Sensirion Holding AG: Challenging 2023 due to the ongoing slump in consumption and global inventory corrections; Returning to growth path in 2024
Sensirion Holding AG faces challenges in 2023 with a decline in sales due to weak demand and inventory corrections, but anticipates a return to growth in 2024 supported by new product launches and market opportunities -
COMMUNIQUÉ DE PRESSE
bettermoo(d) Provides Details of the Special Investors Announcement on Wednesday, March 13, 2024
bettermoo(d) Food Corporation announces details for special investors announcement regarding a new development to be shared by CEO Nima Bahrami. Conference call scheduled for March 13, 2024, with press release following. Company focuses on innovative plant-based dairy-alternative products -
